NMD Pharma A/S
5 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of NMD670 in Adult Patients With Type 1 and Type 2 Charcot-Marie-Tooth Disease (NCT06482437) | NMD Pharma A/S | 2024-09-30 |
| Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis (NCT06414954) | NMD Pharma A/S | 2024-05-16 |
| Safety and Efficacy of NMD670 in Ambulatory Adult Patients With Type 3 Spinal Muscular Atrophy (NCT05794139) | NMD Pharma A/S | 2023-09-21 |
| Observational Study of Neuromuscular Function in CMT Type 1&2 and Healthy Controls (NCT04980807) | NMD Pharma A/S | 2021-04-07 |
| Investigating Loss of Neuromuscular Junction Transmission Fidelity in Older Adults (NCT04904926) | NMD Pharma A/S | 2021-03-16 |
Track NMD Pharma A/S automatically
Every clearance here is in the API, with alerts when new ones post.